There is a license error on this site:
License has expired
The Web site remains functional, but this message will be displayed until the license error has been corrected.

To correct this error:If you do not have a license file, please request one from EPiServer License Center.
The Novel Use Of Hydroxyurea in an African Region With Malaria (NOHARM) Study Skip to main content

Return to Previous Page

The Novel Use Of Hydroxyurea in an African Region With Malaria (NOHARM) Study

February 08, 2016

A video about the University of Minnesota's Clinical and Translational Science Institute study on the efficacy of hydroxyurea for children with sickle cell anemia (SCA) in a malaria endemic region within sub-Saharan Africa.